MedTrace Logo

Cognitive Impairment and Upper Extremity Performance in COPD

NCT05137483 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-11-30

No results posted yet for this study

Summary

Within the scope of this study, COPD patients will be divided into two groups according to cognitive dysfunction.

Pulmonary function test, COPD assessment scale, Mini-Mental State Examination and Montreal Cognitive Assessment Scale, 6 min pegboard ring test, grip strength measurement, Fatigue Impact Scale and St.George Respiratory Questionnaire will be applied to the groups.

Conditions

Interventions

OTHER

Functional tests

We will apply upper extremity performance tests, hand grip measurements, and scales measuring fatigue and quality of life to the groups.

Sponsors & Collaborators

  • Izmir Katip Celebi University

    lead OTHER

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-19
Primary Completion
2022-06-30
Completion
2022-07-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05137483 on ClinicalTrials.gov